US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.29

+0.59351.71%

Post-market: 35.380.0865+0.25%16:00 EDT

Volume:148

Turnover:5K

Market Cap:16.59M

PE:- -

High:35.29

Open:35.23

Low:35.23

Close:34.70

52wk High:37.90

52wk Low:30.79

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.41

T/O Rate:0.03%

Dividend:0.41

Dividend Rate:1.16%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Pharma Lobby Sues Trump Administration over Medicare Drug Price Cuts

Eli Lilly is Maintained at Overweight by Morgan Stanley

What Eli Lilly Stock's First Line Jaypirca Approval Means For Shareholders

Simply Wall St.

AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations

AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer

Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc

THOMSON REUTERS

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419

MT Newswires Live

Innovative drug stock with 300% gain issues risk warning after severe price anomaly

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Calendar of U.S. Earnings Expected in the Week Ahead

AlzeCure Pharma to Present at Redeye Neurology Day

Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day

Perrigo Co. PLC Stock Underperforms Tuesday When Compared to Competitors

Veru initiated with a Buy at WestPark Capital

AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says

MT Newswires Live

SMAIO Signs Sales Agency Agreement with DePuy Synthes for US Market

Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/MEDX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.2935,"timestamp":1791576000000,"preClose":34.7,"halted":0,"volume":148,"hourTrading":{"tag":"盘后","latestPrice":35.38,"preClose":35.2935,"latestTime":"16:00 EDT","volume":1,"amount":35.38,"timestamp":1791576001394,"change":0.0865,"changeRate":0.002451,"amplitude":0},"delay":0,"changeRate":0.017103746397694488,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Post-Mkt","change":0.5935,"latestTime":"10-09 19:09:41 EDT","open":35.23,"high":35.2935,"low":35.23,"amount":5235,"amplitude":0.00183,"askPrice":37,"askSize":35,"bidPrice":26,"bidSize":50,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":34.7,"sharesOutstanding":569946,"nav":35.07,"aum":16481006.22,"dividendRate":0.011611,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.38,"preClose":35.2935,"latestTime":"16:00 EDT","volume":1,"amount":35.38,"timestamp":1791576001394,"change":0.0865,"changeRate":0.002451,"amplitude":0},"volumeRatio":0.409518},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.409518,"shares":469946,"dividePrice":0.4098,"high":35.2935,"amplitude":0.00183,"preClose":34.7,"low":35.23,"week52Low":30.79,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.2935,"committee":0.176471,"eps":0,"divideRate":0.011611,"volume":148,"delay":0,"ttmEps":0,"open":35.23,"prevYearClose":33.2024,"prevWeekClose":34.6588,"prevMonthClose":35.2817,"prevQuarterClose":35.2817,"fiveDayClose":34.6588,"twentyDayClose":34.9572,"sixtyDayClose":35.3775},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","LU0320765489.SGD","LFSC","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BBP","BK4578","SYNB","TECB","IE00BFTCPJ56.SGD","PINK","BMED","IBB","BK4585","XLVX","MEDX","PSCH","IE0002141913.USD","LU0070302665.USD","BK4588","IE00B4R5TH58.HKD","IDNA","IE0009355771.USD","NVS","MEDI","GDOC","BK4007","IYH","NVIB","LU0211331839.USD","GNMX","FRTY","MRNX","LABU","TBXU","IE00BJT1NW94.SGD","MRNY","BK4532","RSPH","PPH","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673019301","title":"Pharma Lobby Sues Trump Administration over Medicare Drug Price Cuts","url":"https://stock-news.laohu8.com/highlight/detail?id=2673019301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673019301?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:04","pubTimestamp":1791385489,"startTime":"0","endTime":"0","summary":"UPDATE 4-Pharma lobby sues Trump administration over Medicare drug price cutsOct 7 (Reuters)-The pharmaceutical industry's top lobby group on Wednesday sued to invalidate the Trump administration's ef","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nL6N45T0XY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","PPH","IE00BJJMRY28.SGD","VHT","TMED","OZEM","LU2023250504.SGD","ILDR","GDOC","LU1720051017.SGD","FTXH","MEDX","LU2213496289.HKD","SGXZ51526630.SGD","WDNA","LLII","CANC","LU2237443465.HKD","ELIL","LU0256863811.USD","SG9999001176.SGD","LU2237443382.USD","LU2168564495.EUR","FHLC","PFE","PJP","IHE","IE0005OL40V9.USD","IXJ","LU2089284900.SGD","XLV","LLYZ","LU1979441026.SGD","THNR","RXL","ELIS","TRUH","HRTS","JDOC","IYH","LU2596442595.SGD","MEDI","AGNG","LU2602419157.SGD","SG9999002224.SGD","LLY","CURE","LLYX","LU2168564149.EUR","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673901629","title":"Eli Lilly is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2673901629","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673901629?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:42","pubTimestamp":1791384120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LLY/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU1988902786.USD","LU2211815571.USD","LU1145028129.USD","SG9999015952.SGD","LU0234572021.USD","LU2462157665.USD","LU2168564495.EUR","LU2468319806.SGD","LU2112291526.USD","LU1035775433.USD","LU0225283273.USD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU2108987350.USD","LU2750360997.AUD","LU1629891620.HKD","LU1064131342.USD","PJP","CANC","LU2471134879.HKD","IE00BJJMRY28.SGD","LU0094547139.USD","LU1232071149.USD","LU2168564065.EUR","LU2462591350.SGD","LU2471134523.USD","LU2089284900.SGD","LU1868836591.USD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","IE00BJLML261.HKD","LU2271345857.HKD","LU1069344957.HKD","OZEM","IE0009355771.USD","LU0354030511.USD","LU0158827781.USD","LU0320765059.SGD","LU2552382132.HKD","LU0820562030.AUD","LU1280957306.USD","LU2756315318.SGD","LU1720051017.SGD","MEDX","LU1551013425.SGD","LU0417517546.SGD","LU1366192091.USD","LLYZ","LU1868836914.USD","LU2746668974.SGD","LU0097036916.USD","LU0006306889.USD","JDOC","LU2417539215.USD","LU0158827948.USD","LU0964807845.USD","LU0323591593.USD","LU0203201768.USD","ELIS","LU2552382058.USD","LU1093756325.SGD","BK4599","SG9999015978.USD","LU0943347566.SGD","LU2063271972.USD","LU0471298777.SGD","LU2456880835.USD","LU2023250330.USD","LU1551013342.USD","LU2491049909.HKD","LU0471298694.HKD","LU2360106947.USD","LU0882574055.USD","LU0786609619.USD","LU0256863902.USD","LU0823434740.USD","LU1983299246.USD","RXL","LU0708995401.HKD","IE00BN29S564.USD","IE0005OL40V9.USD","LU2602419157.SGD","LU1989771016.USD","LU2237438978.USD","LU0823416689.USD","IE00B2B36J28.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU2361045086.USD","IE00BKDWB100.SGD","IYH","LU2106854487.HKD","IE00BKPKM429.USD","SGXZ57979304.SGD","SG9999018857.SGD","LU2023250504.SGD","LU0456855351.SGD","LU0122379950.USD","LU0320765992.SGD","MHIP","BK4534","LU1712237335.SGD","LLII","IE00BJJMRX11.SGD","LU0106261372.USD","LU0289739699.SGD","LU1868837136.USD","LU0096364046.USD","LU1623119135.USD","IE0004445015.USD","LU2265009873.SGD","LU2357305700.SGD","WDNA","SG9999018865.SGD","IHE","LU0198837287.USD","IE00B7KXQ091.USD","SGXZ81514606.USD","XLV","SG9999001176.SGD","LU2750360641.GBP","TRUH","LU0061475181.USD","LU0109394709.USD","HRTS","SG9999015945.SGD","SG9999017495.SGD","LU0133085943.USD","VHT","LU2264538146.SGD","LU2237443465.HKD","LU1291159041.SGD","LU1023059063.AUD","LU0109391861.USD","IE00BK4W5L77.USD","LU0256863811.USD","BK4585","AGNG","LU0820561818.USD","LU2237443622.USD","LU0889565916.HKD","LU0210536198.USD","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1127390331.HKD","LU1057294990.SGD","SG9999014880.SGD","LU2236285917.USD","PPH","IE00BFSS7M15.SGD","LU1093756168.USD","IE0002141913.USD","LU1979441026.SGD","LU0354030438.USD","LU0683600562.USD","LU2087625088.SGD","ILDR","LU0882574139.USD","LU2491050154.USD","LU2896262040.SGD","LU0114720955.EUR","LU1548497426.USD","LU2237443549.SGD","LU2237443978.SGD","LU2361044949.HKD","LU2237443382.USD","LU1061106388.HKD","LU0820561909.HKD","BK4533","LU2213496289.HKD","SG9999014906.USD","LU2028103732.USD","LLYX","SG9999015986.USD","LU0079474960.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU2111349929.HKD","LU0316494557.USD","LU0238689110.USD","LU0203202063.USD","LU0058720904.USD","THNR","LU2168564222.USD","LU0787776722.HKD","GDOC","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0353189763.USD","LU1917777945.USD","MEDI","SG9999001176.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU0266013472.USD","LU2471134796.USD","LU2552382215.SGD","TMED","BK4516","FTXH","LU2361044865.SGD","SG9999014898.SGD","SG9999014914.USD","LU1868837300.USD","LU2023251221.USD","IE0004445239.USD","CURE","IXJ","LU0353189680.USD","IE00B4JS1V06.HKD","LU2237443895.HKD","LU1720051108.HKD","BK4007","LU0174119429.USD","LU2746668461.USD","LU1868836757.USD","ELIL","IE0001KFT4U8.USD","LU0385154629.USD","LU0345770993.USD","LU0689472784.USD","BK4581","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0466842654.USD","LU1804176565.USD","LU1814569148.SGD","LU2168563687.JPY","LU1267930730.SGD","LU2168564149.EUR","BK4588","LU2089283258.USD","LU0640476718.USD","LU0345770308.USD","LU2089984988.USD","LU2471134952.CNY","LU2461242641.AUD","LU2324357040.USD","IE00B775H168.HKD","IE00B1XK9C88.USD","LU0823434583.USD","LLY","LU1974910355.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673801901","title":"What Eli Lilly Stock's First Line Jaypirca Approval Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2673801901","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673801901?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:31","pubTimestamp":1791383477,"startTime":"0","endTime":"0","summary":"Eli Lilly received an expanded FDA approval for Jaypirca, allowing first-line use in adults with previously untreated CLL or SLL without a known 17p deletion, based on the Phase 3 BRUIN CLL-313 trial.\nThe broader Jaypirca label adds another potential growth driver in Eli Lilly’s oncology portfolio. This sits alongside its large incretin and diabetes franchises and helps diversify the future revenue mix.\nWe will now look at how Eli Lilly's wider first-line Jaypirca approval could reshape the...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/285467-card/1788981702614","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/285467-card/1788981702614"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/what-eli-lilly-stocks-first-line-jaypirca-approval-means-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/what-eli-lilly-stocks-first-line-jaypirca-approval-means-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","LU0345770993.USD","SGXZ81514606.USD","LU0345770308.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","XLV","IE00BJLML261.HKD","SG9999017495.SGD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013770","title":"AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013770","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013770?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:14","pubTimestamp":1791378840,"startTime":"0","endTime":"0","summary":"CEO interview explores Ampligen’s potential to extend survival and improve quality of life as AIM advances toward pivotal development Access the article here OCALA, Fla., Oct.  07, 2026 (GLOBE NEWSWIR","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376540/29489/en/aim-immunotech-s-strategy-to-address-immune-resistance-in-pancreatic-cancer-featured-in-biotuesdays.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","MEDX","NVIB","HYLG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013460","title":"Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013460?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:09","pubTimestamp":1791378540,"startTime":"0","endTime":"0","summary":"Since going public, Veraxa Biotech has endured a deep slump that has pushed its stock into single-digit territory. Its recovery may hinge on the adoption of new drug-testing protocols to accelerate it","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1829250122.USD","RXL","TRUH","LU2089284900.SGD","XBI","GLAM","LU1057294990.SGD","LU2125909247.SGD","LU1162221912.USD","LU1934455194.USD","LU1929549753.HKD","AZN","IE00B3PB1722.GBP","LU0708994859.HKD","BK4581","LU0198837287.USD","IE00BLSP4452.SGD","IXJ","IE00BN8TJ469.HKD","LU2456880835.USD","AGNG","SG9999001440.SGD","FTXH","LU0942090050.USD","LU0965509101.SGD","BK4534","FHLC","XLV","LU1923622614.USD","PJP","BK4566","IYH","JDOC","VHT","LU2133065610.SGD","LU0949170772.SGD","LU1720051108.HKD","PPH","LU0114720955.EUR","LU0912757837.SGD","ABBV","VRXA","AZNH","MEDX","LU1720051017.SGD","LU0122379950.USD","LU0456855351.SGD","LU1839511570.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018273","title":"AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018273","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018273?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:36","pubTimestamp":1791376566,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the U.S. FDA has granted two Breakthrough Therapy Designations for telisotuzumab adizutecan in colorectal cancer and n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvies-telisotuzumab-adizutecan-gets-two-fda-breakthrough-therapy-designations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvies-telisotuzumab-adizutecan-gets-two-fda-breakthrough-therapy-designations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989772923.USD","ABBV","JDOC","IXJ","IE000F7OJYX1.SGD","IE00B4R5TH58.HKD","LU1551013425.SGD","IE00BGHQF631.EUR","PJP","LU0689472784.USD","LU0738911758.USD","LU1496350502.SGD","SG9999003800.SGD","LU2112291526.USD","VHT","LABU","XLV","BK4581","LU0158827948.USD","FTXH","GLAM","BK4550","MEDX","LU1839511570.USD","AGNG","LU2089284900.SGD","FHLC","TRUH","LU1670627923.USD","LU0965508806.USD","SG9999015986.USD","LU0417517546.SGD","IE00BJT1NW94.SGD","LU0456855351.SGD","IE00BN8TJ469.HKD","LU1548497426.USD","SG9999015978.USD","LU1496350171.SGD","LU0708994859.HKD","LU1989772840.SGD","IE00BLSP4239.USD","IYH","LU0029864427.USD","LU2237443549.SGD","LU1093756325.SGD","IE0004445239.USD","PPH","IE00B19Z3581.USD","RXL","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018498","title":"AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018498","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018498?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:32","pubTimestamp":1791376326,"startTime":"0","endTime":"0","summary":"AbbVie says FDA grants breakthrough therapy status for ABBV-400 in metastatic colorectal cancerAbbVie won two FDA Breakthrough Therapy Designations for telisotuzumab adizutecan, an investigational c-M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL6jsywg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","BK4559","LU1732799900.SGD","XLV","LU0965509283.SGD","LU1989772923.USD","IE00B42XCP33.USD","RXL","LU0256863811.USD","MEDX","PJP","SG9999015952.SGD","LU0289961442.SGD","LU1989771016.USD","IE000BZT7R73.USD","LU2237443465.HKD","LU0198837287.USD","FTXH","IE00BFTCPJ56.SGD","LU1003077747.HKD","FHLC","IE00BJT1NW94.SGD","LU1074936037.SGD","LU0661504455.SGD","LU0203347892.USD","AGNG","LU0122379950.USD","LU1923622614.USD","LU1548497426.USD","JDOC","LU0058720904.USD","BK4534","VHT","IE00BDGV0183.EUR","IE00BLSP4452.SGD","LU0965509101.SGD","IE00BN8TJ469.HKD","LU0795875086.SGD","PPH","LU1732800096.USD","LU2133065610.SGD","TRUH","BK4550","IXJ","IYH","IE00B2B36J28.USD","LU0124676726.USD","LU1093756325.SGD","LU2125909247.SGD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018199","title":"Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018199?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA8YWCC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGNG","LU0708994859.HKD","BK4550","LU0472753341.HKD","LU0456855351.SGD","PPH","LU1496350502.SGD","GLAM","LU1244550577.SGD","XLV","LU1244550221.USD","BK4581","LU1720051017.SGD","LU0234572021.USD","VHT","FTXH","TRUH","LU0912757837.SGD","LU1585245621.USD","IYH","LU0211327993.USD","LU0211328371.USD","LU1267930573.SGD","LU1718418525.SGD","MEDX","ABBV","LU1670627923.USD","LU2087621335.USD","IE00BLSP4239.USD","LU0417517546.SGD","SG9999015978.USD","FHLC","IXJ","IE00BDGV0183.EUR","LU1670628061.USD","PJP","LU0943347566.SGD","RXL","IE00B19Z3581.USD","JDOC","LU0949170772.SGD","LU0320765646.SGD","LU1037948541.HKD","LU1934455277.USD","LU0859254822.USD","LU1023059063.AUD","LU1236620750.USD","LU0170899867.USD","LU0029864427.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018615","title":"Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018615","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018615?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:23","pubTimestamp":1791375836,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) has an average rating of overweight and mean price target of $1,363.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B1BXHZ80.USD","LU1988902786.USD","LU2211815571.USD","LU1145028129.USD","SG9999015952.SGD","LU0234572021.USD","LU2462157665.USD","LU2168564495.EUR","LU2468319806.SGD","LU2112291526.USD","LU1035775433.USD","LU0225283273.USD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU2108987350.USD","LU2750360997.AUD","LU1629891620.HKD","LU1064131342.USD","PJP","CANC","LU2471134879.HKD","IE00BJJMRY28.SGD","LU0094547139.USD","LU1232071149.USD","LU2168564065.EUR","LU2462591350.SGD","LU2471134523.USD","LU2089284900.SGD","LU1868836591.USD","SGXZ51526630.SGD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","IE00BJLML261.HKD","LU2271345857.HKD","LU1069344957.HKD","OZEM","IE0009355771.USD","LU0354030511.USD","LU0158827781.USD","LU0320765059.SGD","LU2552382132.HKD","LU0820562030.AUD","LU1280957306.USD","LU2756315318.SGD","LU1720051017.SGD","MEDX","LU1551013425.SGD","LU0417517546.SGD","LU1366192091.USD","LLYZ","LU1868836914.USD","LU2746668974.SGD","LU0097036916.USD","LU0006306889.USD","JDOC","LU2417539215.USD","LU0158827948.USD","LU0964807845.USD","LU0323591593.USD","LU0203201768.USD","ELIS","LU2552382058.USD","LU1093756325.SGD","BK4599","SG9999015978.USD","LU0943347566.SGD","LU2063271972.USD","LU0471298777.SGD","LU2456880835.USD","LU2023250330.USD","LU1551013342.USD","LU2491049909.HKD","LU0471298694.HKD","LU2360106947.USD","LU0882574055.USD","LU0786609619.USD","LU0256863902.USD","LU0823434740.USD","LU1983299246.USD","RXL","LU0708995401.HKD","IE00BN29S564.USD","IE0005OL40V9.USD","LU2602419157.SGD","LU1989771016.USD","LU2237438978.USD","LU0823416689.USD","IE00B2B36J28.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU2361045086.USD","IE00BKDWB100.SGD","IYH","LU2106854487.HKD","IE00BKPKM429.USD","SGXZ57979304.SGD","SG9999018857.SGD","LU2023250504.SGD","LU0456855351.SGD","LU0122379950.USD","LU0320765992.SGD","MHIP","BK4534","LU1712237335.SGD","LLII","IE00BJJMRX11.SGD","LU0106261372.USD","LU0289739699.SGD","LU1868837136.USD","LU0096364046.USD","LU1623119135.USD","IE0004445015.USD","LU2265009873.SGD","LU2357305700.SGD","WDNA","SG9999018865.SGD","IHE","LU0198837287.USD","IE00B7KXQ091.USD","SGXZ81514606.USD","XLV","SG9999001176.SGD","LU2750360641.GBP","TRUH","LU0061475181.USD","LU0109394709.USD","HRTS","SG9999015945.SGD","SG9999017495.SGD","LU0133085943.USD","VHT","LU2264538146.SGD","LU2237443465.HKD","LU1291159041.SGD","LU1023059063.AUD","LU0109391861.USD","IE00BK4W5L77.USD","LU0256863811.USD","BK4585","AGNG","LU0820561818.USD","LU2237443622.USD","LU0889565916.HKD","LU0210536198.USD","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1127390331.HKD","LU1057294990.SGD","SG9999014880.SGD","LU2236285917.USD","PPH","IE00BFSS7M15.SGD","LU1093756168.USD","IE0002141913.USD","LU1979441026.SGD","LU0354030438.USD","LU0683600562.USD","LU2087625088.SGD","ILDR","LU0882574139.USD","LU2491050154.USD","LU2896262040.SGD","LU0114720955.EUR","LU1548497426.USD","LU2237443549.SGD","LU2237443978.SGD","LU2361044949.HKD","LU2237443382.USD","LU1061106388.HKD","LU0820561909.HKD","BK4533","LU2213496289.HKD","SG9999014906.USD","LU2028103732.USD","LLYX","SG9999015986.USD","LU0079474960.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU2111349929.HKD","LU0316494557.USD","LU0238689110.USD","LU0203202063.USD","LU0058720904.USD","THNR","LU2168564222.USD","LU0787776722.HKD","GDOC","IE00BFTCPJ56.SGD","LU1323610961.USD","LU0353189763.USD","LU1917777945.USD","MEDI","SG9999001176.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU0266013472.USD","LU2471134796.USD","LU2552382215.SGD","TMED","BK4516","FTXH","LU2361044865.SGD","SG9999014898.SGD","SG9999014914.USD","LU1868837300.USD","LU2023251221.USD","IE0004445239.USD","CURE","IXJ","LU0353189680.USD","IE00B4JS1V06.HKD","LU2237443895.HKD","LU1720051108.HKD","BK4007","LU0174119429.USD","LU2746668461.USD","LU1868836757.USD","ELIL","IE0001KFT4U8.USD","LU0385154629.USD","LU0345770993.USD","LU0689472784.USD","BK4581","LU2491050071.SGD","IE00BK4W5M84.HKD","LU0466842654.USD","LU1804176565.USD","LU1814569148.SGD","LU2168563687.JPY","LU1267930730.SGD","LU2168564149.EUR","BK4588","LU2089283258.USD","LU0640476718.USD","LU0345770308.USD","LU2089984988.USD","LU2471134952.CNY","LU2461242641.AUD","LU2324357040.USD","IE00B775H168.HKD","IE00B1XK9C88.USD","LU0823434583.USD","LLY","LU1974910355.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192153114","title":"Innovative drug stock with 300% gain issues risk warning after severe price anomaly","url":"https://stock-news.laohu8.com/highlight/detail?id=1192153114","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192153114?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:20","pubTimestamp":1791372036,"startTime":"0","endTime":"0","summary":"On October 7, Novoprotein Scientific Inc. (688137.SH) released an announcement regarding severe abnormal fluctuations in its stock trading and a risk warning, noting that as of the close on September...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","BK1161","MEDX","LNGR","IBBQ","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673975950","title":"Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2673975950","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673975950?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370800,"startTime":"0","endTime":"0","summary":"– Data showed improvements in an objective measure of impaired eye movement associated with Parkinson’s disease, with a correlation between reductions in LRRK2 cerebrospinal fluid (CSF) biomarkers to ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376329/0/en/arvinas-shares-novel-oculomotor-and-biomarker-data-from-phase-1-clinical-trial-of-arv-102-in-patients-with-parkinson-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","BK4109","LU2463526074.USD","CSF","HYLG","PSP","ASH","GDOC","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673094317","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2673094317","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673094317?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:00","pubTimestamp":1791367200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. Levi Strauss & Co. Class A                      3Q       .36   4:10 PM. Helen of Troy Limited                           2Q       .50   6:45 AM. Delta Air Lines Inc.                             3Q      1.85   6:30 AM. New Horizon Aircraft Ltd. Class A               1Q      (.09)  7:00 AM. Albertsons Companies Inc. Class A                2Q       .33   7:30 AM. Goldman Sachs Grp Inc.                            3Q     13.30   7:30 AM. JPMorgan Chase & Co.                             3Q      5.90   7:00 AM. Wells Fargo & Company                            3Q      1.84   7:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","C","LU1868837136.USD","IE000M9KFDE8.USD","UN","LU0316494557.USD","LU1868836757.USD","XLV","LU0053666078.USD","IE00BWXC8680.SGD","LU0058720904.USD","LU2028103732.USD","LU1732799900.SGD","LU2361044865.SGD","LU1261432733.SGD","LU2954938101.SGD","LU0742537680.HKD","IE0004086264.USD","LU2471134523.USD","LU1791710400.SGD","LU0265550359.USD","IE00BVYPNV92.GBP","BK4568","LU1069347547.HKD","LU0323591593.USD","LU1778281490.HKD","LU1929549753.HKD","LU2357627491.SGD","LU1988902786.USD","LU0175139822.USD","BK4207","LU2237438978.USD","IE00BBT3K403.USD","LU1059921491.USD","IE00B19Z3581.USD","LU2089283258.USD","BK4596","FHLC","LU1935042991.SGD","LU0912757837.SGD","LU2125154778.USD","LU2756315318.SGD","MHIP","LU1066051225.USD","LU2054465674.USD","LU0982800491.AUD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0708995401.HKD","LU0154236417.USD","LU0061475181.USD","IE00BFMHRM44.USD","LU0757428866.USD","LU1934455863.HKD","LU2362541513.USD","LU0731783394.SGD","IE0004091025.USD","LU2236285917.USD","LU2417539215.USD","LU0426417589.USD","LU0320765059.SGD","HOVR","SGXZ81514606.USD","LU2999663052.SGD","LU1791807156.HKD","SGXZ99366536.SGD","LU0417517546.SGD","LU1235295455.SGD","LU0265550946.USD","BK4123","LU0426412945.USD","LU0708994859.HKD","LU1064131342.USD","LU1228905037.USD","IE000BZT7R73.USD","LU0158827948.USD","IE0034235295.USD","BK4211","LU1854103824.USD","LU0267386448.USD","IE00B3S45H60.SGD","LU0109391861.USD","IE00BDRTCR15.USD","LU2324357040.USD","PJP","LU0079474960.USD","LU1883839398.USD","LU1043141396.HKD","LU0823416689.USD","IE00B3T34201.USD","LU2456880835.USD","LU1917777945.USD","LU2065732104.USD","IE00B4JS1V06.HKD","LU0942090050.USD","BK4127","LU2213496289.HKD","LU0320765646.SGD","LU1267930227.SGD","BK4524","LU2361045086.USD","LU2112291526.USD","GDOC","IE00BZ9MQY76.HKD","LU0256863811.USD","FBK","IE00B894F039.SGD","LU0994945656.USD","LU2108987350.USD","SG9999002224.SGD","LU0210536198.USD","LU1066053197.SGD","APLX","LU0861579265.USD","LU1548497426.USD","LU2168564222.USD","IE00BJTD4N35.SGD","LU1116320901.HKD","LU0122379950.USD","LU1481011911.USD","IE0002270589.USD","MNRS","VFH","IE00B19Z4B17.USD","LU1363072403.SGD","SG9999002232.USD","LU0158827781.USD","JPM","IE00BFTCPJ56.SGD","LU1791710582.SGD","IE00BZ1G4Q59.USD","IE00B19Z8W00.USD","LU1934455194.USD","SGXZ31699556.SGD","SG9999001440.SGD","LU0187121727.USD","LU1854104046.USD","LU2362540622.SGD","LU2552382132.HKD","PGR","LU1674673428.USD","SG9999003800.SGD","IHE","LU0170899867.USD","LU1732800096.USD","SG9999013999.USD","LU0345770993.USD","LU0070302665.USD","BK4609","LU0345769128.USD","KBWB","LU1934455277.USD","JPMO","BK4209","FDIG","LU1868836914.USD","LU1668664300.SGD","LU1366192091.USD","LU0130517989.USD","FTXO","LU0077335932.USD","IE00B4R5TH58.HKD","BK4552","LU0096364046.USD","LU0203347892.USD","LU0432979614.USD","BK4116","LU0859254822.USD","LU1509826696.USD","LU0057025933.USD","LU0211331839.USD","LU2355687059.USD","LU0795875169.SGD","LU0882574139.USD","BK4532","LU1032466523.USD","IE00BKDWB100.SGD","LU2168563687.JPY","LU1037948541.HKD","LU2360032135.SGD","LU1551013425.SGD","LU2746668461.USD","IE000WAW04H5.SGD","LU0964807845.USD","DPZ","LU0069063385.USD","LU1035773651.USD","LU1481011671.HKD","LU0310799852.SGD","TRUH","FNCL","LU0466842654.USD","LU2168564495.EUR","IE00BK4W5L77.USD","BK4187","LU1003077747.HKD","BK4608","LU0965509101.SGD","LU2462157665.USD","LU0203345920.USD","LU1121112475.USD","BK4177","LU1196500208.SGD","LU1506573853.SGD","LU2125154935.USD","IE00BJJMRX11.SGD","LU2211815571.USD","BK4504","IE0001KFT4U8.USD","IHF","IE00BYXW3230.USD","IE0005OL40V9.USD","LU0971096721.USD","SG9999014898.SGD","LU2244417387.USD","LU0965508806.USD","UNHG","LU0566484027.USD","LU2491050154.USD","IE00B66KJ199.SGD","KBWP","LU0731783048.USD","LU1280957306.USD","LU1983260115.SGD","LU1983299246.USD","BK4082","IE00B3PB1722.GBP","LU2746668974.SGD","IE00BVYPNW00.USD","LU2237443549.SGD","LU2491049909.HKD","BK4547","LEVI","LU0198837287.USD","LU2023250504.SGD","IE00BGHQF631.EUR","TRUF","LU1894683348.USD","SG9999004303.SGD","LU0097036916.USD","LU0138981039.USD","LU0251132253.USD","LU2129689605.HKD","LU2237443895.HKD","IE00BKVL7J92.USD","BK4557","GS","LU1559883803.SGD","LU0820561818.USD","BK4581","LU0251142724.SGD","LU0820562030.AUD","LU2111349929.HKD","LU1267930573.SGD","SG9999018865.SGD","IE00BJT1NW94.SGD","IE000MB6IJN5.SGD","LU2552382215.SGD","LU1244550221.USD","BK4023","IE0031619046.USD","LU2462591277.SGD","BK4533","LU0661504455.SGD","IE00BN29S564.USD","IE00BLSP4239.USD","LU2602419157.SGD","LU0742534661.SGD","LU0545039389.USD","LU1815336091.USD","LU0052756011.USD","LU0320765489.SGD","LU0683600562.USD","LU1037948897.HKD","ANGO","LU0689472784.USD","LU1599440770.SGD","LU0980610538.SGD","LU2237443382.USD","VHT","LU0114720955.EUR","BK4008","IE0000B7K699.USD","LU2242649171.HKD","IE00B19Z8X17.USD","LU0128525689.USD","LU0289739343.SGD","SG9999014914.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","RXL","LU1043141123.HKD","IE00B1XK9C88.USD","LU0545562505.USD","LU0094547139.USD","LU1244550494.USD","LU0976567544.SGD","LU1066051498.USD","BYRN","SGXZ80539844.SGD","IAK","LU1366333091.USD","LU1868837300.USD","SGXZ57979304.SGD","LU1868836591.USD","LU0496365809.HKD","LU0006306889.USD","LU2237443465.HKD","LU0143551892.USD","IBLC","IE00B775H168.HKD","LU2750360997.AUD","IE00BFXG1179.USD","LU0011850046.USD","LU0238689110.USD","IE00BSNM7G36.USD","LU0648001328.SGD","BK4588","LU2461242641.AUD","DAPP","LU0289739699.SGD","LU0738911758.USD","LU0965509010.AUD","IXJ","LU0772969993.USD","BK4592","IE0004445239.USD","LU1201861249.SGD","LU2168564065.EUR","RGP","LU1074936037.SGD","SGXZ23171101.USD","XLF","IE000F7OJYX1.SGD","LU1670628061.USD","LU0130102774.USD","LU0029864427.USD","LU0210528500.USD","LU0234570918.USD","LU0314106906.USD","LU2023250843.SGD","ACI","LU0456855351.SGD","LU2089984988.USD","LU2106854487.HKD","LU2471134879.HKD","LU0477156953.USD","LU2279689827.SGD","SG9999011175.SGD","UNHW","LU2552382058.USD","IE0004445015.USD","LU1670627923.USD","LU0868494617.USD","LU2430703251.USD","LU1804176565.USD","LU1267930730.SGD","LU0289961442.SGD","LU2264538146.SGD","BK4550","GSX","IE00B42XCP33.USD","APLZ","LU0792757196.USD","LU0353189680.USD","IXG","LU2596442595.SGD","LU0965509283.SGD","LU2271345857.HKD","HRTS","BK4154","LU0289960550.SGD","LU0342679015.USD","LU0354030511.USD","IE0009355771.USD","LU1291159041.SGD","LU2403377893.USD","LU0795875086.SGD","LU1674673691.USD","MEDX","BK4113","WFC","IE00BLSP4452.SGD","LU1221951046.USD","LU2592432038.USD","LU0640476718.USD","IE0034235188.USD","LU2468319806.SGD","LU1496350502.SGD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","SG9999001176.SGD","LU0949170772.SGD","LU1894683264.USD","LU2129689431.USD","SG9999017495.SGD","TLRY","LU1267930813.SGD","LU0072461881.USD","IE00B2B36J28.USD","LU1720051108.HKD","LU0215105999.USD","LU2237443978.SGD","LU2487616109.SGD","LU0107464264.USD","SGXZ51526630.SGD","LU0048584097.USD","LU0345769631.USD","LU0511384066.AUD","SG9999018857.SGD","LU1221951129.SGD","LU0251131958.USD","SG9999014880.SGD","LU0234572021.USD","IYG","BK4559","FTXG","IE00BJJMRY28.SGD","LU1323610961.USD","LU1066051811.HKD","BK4501","LU1228905540.USD","LU2381873111.SGD","LU2471134952.CNY","LU0124676726.USD","LU1814569148.SGD","SG9999014906.USD","LU0070217475.USD","LU0211326839.USD","LU2505996681.GBP","TMED","LU1144417596.USD","LU0211328371.USD","IE00BHPRN162.USD","LU1496350171.SGD","LU0048573561.USD","IE00BN8TJ469.HKD","LU2237443622.USD","LU1061106388.HKD","LU0106831901.USD","LU0157215616.USD","LU0266013472.USD","IE00B19Z9P08.USD","JETS","LU1551013342.USD","BMED","LU1629891620.HKD","BK4182","LU2505996509.AUD","LU0310800965.SGD","LU1162221912.USD","IE00B775SV38.USD","IYH","LU0553294199.USD","LU0345770308.USD","LU2168564149.EUR","LU2347655156.SGD","IE0034235303.USD","LU0256863902.USD","DAL","SG9999001176.USD","UNH","PEP","LU0943347566.SGD","LU1032955483.USD","IE00B7SZL793.SGD","LU2089284900.SGD","LU2430703095.HKD","SUNH0main","BK4107","LU1057294990.SGD","LU0882574055.USD","LU2896262040.SGD","LU0149725797.USD","LU2087625088.SGD","AZZ","LU0985320562.USD","LU0528227936.USD","BK4585","LU1119994496.HKD","LU0889566641.SGD","LU1430594728.SGD","LU1914381329.SGD","IE00BKPKM429.USD","LU1585245621.USD","LU0208291251.USD","LU2361044949.HKD","UYG","LU1023059063.AUD","JPO","IE00BFSS8Q28.SGD","IE00BJLML261.HKD","BK4534","LU1116320737.USD","UNHU","LU2491050071.SGD","BK4191","IE00BDCRKT87.USD","LU0211326755.USD","LU0098860793.USD","LU2023251221.USD","LU1244550577.SGD","IE00B1BXHZ80.USD","LU1974910355.USD","LU2265009873.SGD","LU2756315664.SGD","IE00B19Z9Z06.USD","LU2129689514.USD","LU2357305700.SGD","LU0689626769.HKD","LU2430703178.SGD","LU2471134796.USD","LU0557290698.USD","LU1145028129.USD","LU1989771016.USD","LU1153585028.USD","LU0472753341.HKD","IE000SO60NU8.SGD","LU0128525929.USD","IE00B7KXQ091.USD","LU0868494708.USD","JNJ","HELE","LU1718418525.SGD","LU0672654240.SGD","LU1084165304.USD","BK4516","LU2023250330.USD","LU2362541273.HKD","BK4566","BK4086","LU0787776722.HKD","IYF","LU0211327993.USD","BK4500","BK4007","TFNS","IE00BDGV0183.EUR","BK4202","IE0002141913.USD","LU2133065610.SGD","IE00BJTD4V19.USD","APLD","IE00B7SZLL34.SGD","LU1267930490.SGD","LU1720051017.SGD","LU0354030438.USD","JDOC","LU0820561909.HKD","FTXH","LU0353189763.USD","IE00B19Z9505.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673096987","title":"AlzeCure Pharma to Present at Redeye Neurology Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673096987","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673096987?lang=en_us&edition=fundamental","pubTime":"2026-10-07 16:05","pubTimestamp":1791360306,"startTime":"0","endTime":"0","summary":"AlzeCure Pharma to present at Redeye Neurology DayAlzeCure Pharma will attend Redeye Neurology Day in Stockholm on Oct. 15, 2026.CEO Martin Jnsson is scheduled to present at 11:15 CEST, including an u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDLM1gvJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","LU0345770993.USD","SGXZ81514606.USD","LU0345770308.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","XLV","IE00BJLML261.HKD","SG9999017495.SGD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673098410","title":"Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673098410","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673098410?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:00","pubTimestamp":1791352800,"startTime":"0","endTime":"0","summary":"Licaminlimab genotype-based precision medicine approach for TNFR1-mediated dry eye disease in PREDICT-1 registrational symptoms trial on track for topline readout around year-end ZUG, Switzerland, Oct","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376181/0/en/oculis-to-highlight-licaminlimab-at-eyecelerator-aao-2026-and-partner-with-neuro-ophthalmology-subspecialty-day.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348723411.USD","LU1720051108.HKD","ONX","BK4605","LU1548497426.USD","LU2357305700.SGD","IE00BD6J9T35.USD","LU0724618433.USD","GDOC","OCS","BMED","LU2360107325.USD","BK4007","LU1861219969.SGD","BK4585","ON","IE00BZ199S13.USD","BK4141","LU1861214812.USD","BK4512","LU1854103824.USD","MEDX","LU1983260115.SGD","LU1854104046.USD","IE00BFMHRM44.USD","LU1720051017.SGD","IDNA","ONG","LU1861220033.SGD","LU1861215975.USD","BK4588","LU1978683503.SGD","LU0124384867.USD","LU2298322129.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673066872","title":"Perrigo Co. PLC Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673066872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673066872?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:29","pubTimestamp":1791322140,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 3.05% to $14.00 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.58% to 7,818.93 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.The stock's fall snapped a two-day winning streak.Perrigo Co. PLC closed 37.71% short of its 52-week high of $22.48, which the company achieved on October 6th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.73% to $254.78, Procter & Gamble Co.  rose 1.69% to $148.41, and Abbott Laboratories  fell 1.94% to $98.16.Trading volume  remained 821,454 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXL","XLP","FSTA","JNJ","BK4559","LU1721429402.USD","UGE","IE000F7OJYX1.SGD","LU1066051498.USD","IE00BKVL7J92.USD","BMED","ABT","LU2129689514.USD","XLV","LU0994945656.USD","GB00BDT5M118.USD","LU1244550221.USD","MEDX","LU0683600562.USD","IE00B4R5TH58.HKD","IHI","FTXH","IE00B19Z3581.USD","IYH","VHT","GDOC","PG","IHE","LU1674673691.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU1551013425.SGD","LU1043141123.HKD","IE00BWXC8680.SGD","LU0070302665.USD","LU2023250330.USD","PJP","TMED","TRUH","JDOC","IE0001KFT4U8.USD","TRUO","LU2471134796.USD","FHLC","LU0345770993.USD","LU1721429741.USD","IXJ","LU1868837300.USD","LU2089984988.USD","PRGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673706884","title":"Veru initiated with a Buy at WestPark Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673706884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673706884?lang=en_us&edition=fundamental","pubTime":"2026-10-07 01:40","pubTimestamp":1791308410,"startTime":"0","endTime":"0","summary":"WestPark Capital initiated coverage of Veru (VERU) with a Buy rating and $28 price target Lead asset enbosarm has completed 27 clinical trials acro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veru-initiated-with-a-buy-at-westpark-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veru-initiated-with-a-buy-at-westpark-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","BK4557","DBB","GDOC","BMED","BK4007","IDNA","NVIB","VERU","MEDX","BK4183","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673050342","title":"AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050342?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:41","pubTimestamp":1791304881,"startTime":"0","endTime":"0","summary":"AbbVie's  Epkinly could become a preferred frontline option in diffuse large B-cell lymphoma, as its phase 3 result looks favorable against other recently positive regimens on a cross-trial basis, UBS Securities said.The investment firm said in a Monday note that the data would support use of Epkinly with R-CHOP chemotherapy, potentially ahead of combinations such as Roche's Polivy and glofitimab.UBS sees a potential multi-billion-dollar opportunity, versus consensus peak sales of just $1 billion to $2 billion for AbbVie, which splits economics with Genmab.The brokerage also noted the study succeeded in a broader patient population than expected, and said it still needs to see full data and safety, which could come at ASH in December.UBS has a neutral rating on AbbVie, with a $260 price target.Price: 267.95, Change: +2.19, Percent Change: +0.83","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0726765562.USD","RXL","LU0069063385.USD","LU1267930573.SGD","TRUH","LU1061106388.HKD","SG9999011175.SGD","LU0310799852.SGD","LU1551013425.SGD","LU0689626769.HKD","GLAM","IE00BDGV0183.EUR","SG9999015978.USD","IE00B3PB1722.GBP","LU2237443382.USD","BK4581","LU0198837287.USD","LU0472753341.HKD","IXJ","LU0256863811.USD","AGNG","FTXH","LU1934455277.USD","LU1718418525.SGD","FHLC","LU2433249047.HKD","XLV","IE0002270589.USD","LU0234572021.USD","LU1923622614.USD","PJP","LU0203345920.USD","SG9999015945.SGD","IYH","JDOC","VHT","IE0002141913.USD","LU0211328371.USD","PPH","LU0029864427.USD","LU2237443895.HKD","LU1074936037.SGD","LU0114720955.EUR","ABBV","LU0289739699.SGD","LU2089984988.USD","MEDX","LU1496350171.SGD","LU0456855351.SGD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673050845","title":"SMAIO Signs Sales Agency Agreement with DePuy Synthes for US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050845","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050845?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:34","pubTimestamp":1791304473,"startTime":"0","endTime":"0","summary":"BRIEF-SMAIO Signs Sales Agency Agreement With DePuy Synthes For US MarketOct 6 (Reuters)-SMAIO SAALSMA.PA:SMAIO - SIGNS SALES AGENCY AGREEMENT WITH DEPUY SYNTHES FOR US MARKETSource text:ID:nBw7kzLQvaFurther company coverage:ALSMA.PA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S14N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU1551013342.USD","LU2468319806.SGD","IE00B3T34201.USD","IE0000B7K699.USD","JNJ","LU0545039389.USD","RXL","LU0289739699.SGD","IE00BGHQF631.EUR","GDOC","BK4568","LU1935042991.SGD","LU0098860793.USD","LU1074936037.SGD","LU1221951129.SGD","BK4592","IE000F7OJYX1.SGD","BMED","VHT","IE00BN8TJ469.HKD","FHLC","LU1585245621.USD","LU0345769631.USD","BK4550","LU2430703095.HKD","PJP","LU0820561909.HKD","IE00BFXG1179.USD","LU1228905037.USD","LU2129689514.USD","FTXH","TRUH","LU0553294199.USD","BK4533","XLV","LU0689626769.HKD","MEDX","IHE","JDOC","IYH","LU1732799900.SGD","IXJ","LU0124676726.USD","SG9999013999.USD","LU1196500208.SGD","LU2403377893.USD","IE00BVYPNV92.GBP","LU0320765646.SGD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673503540","title":"Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2673503540","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673503540?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:30","pubTimestamp":1791304237,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) has completed a Phase 1 trial titled ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lillys-new-basal-insulin-candidate-clears-key-early-trial-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lillys-new-basal-insulin-candidate-clears-key-early-trial-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU0787776722.HKD","SG9999018865.SGD","ILDR","BK4516","BK4599","ELIS","LU1983299246.USD","LU2237443622.USD","SGXZ81514606.USD","LU2462157665.USD","LU2168564149.EUR","LU2089284900.SGD","LU2168564065.EUR","LU1623119135.USD","LU2023250330.USD","SG9999015952.SGD","IE00B1XK9C88.USD","LU1720051017.SGD","LU0256863902.USD","LU2750360641.GBP","SGXZ31699556.SGD","PJP","MEDX","LU0823416689.USD","LU0109391861.USD","SG9999017495.SGD","LU1712237335.SGD","LU0006306889.USD","GB00BDT5M118.USD","LU0174119429.USD","LU1291159041.SGD","SG9999013999.USD","LU0786609619.USD","LU2471134879.HKD","LU1232071149.USD","LU1868837300.USD","SG9999014906.USD","THNR","LU0354030511.USD","AGNG","IE00B775H168.HKD","LU2471134523.USD","LU2471134796.USD","LU2063271972.USD","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2491049909.HKD","SG9999014880.SGD","LU2324357040.USD","LU2746668461.USD","LU1551013425.SGD","LU0198837287.USD","LU0061475181.USD","IE00B4JS1V06.HKD","LU1366192091.USD","IE00BK4W5M84.HKD","IE0004445015.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU1974910355.USD","LU0097036916.USD","LU2361045086.USD","LU2111349929.HKD","LU2211815571.USD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0203202063.USD","LU2089283258.USD","LU0683600562.USD","LU0820561909.HKD","LU0320765059.SGD","LU1323610961.USD","LU1093756325.SGD","SGXZ57979304.SGD","OZEM","LU2552382215.SGD","LU0820562030.AUD","HRTS","LLYX","LU1548497426.USD","LU0158827781.USD","LU0210536198.USD","LU0079474960.USD","LLII","LU0385154629.USD","IE00BJJMRY28.SGD","CURE","LU1551013342.USD","CANC","LU0466842654.USD","LU1061106388.HKD","LU2357305700.SGD","IHE","LU0417517546.SGD","LU2746668974.SGD","LU0234572021.USD","LU0456855351.SGD","SG9999014898.SGD","LU2360106947.USD","LU0889565916.HKD","LU1280957306.USD","LLY","LU1804176565.USD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","BK4534","LU1145028129.USD","LU0823434583.USD","LU1023059063.AUD","LU1868836757.USD","LU0289739699.SGD","LU0345770308.USD","LU0820561818.USD","LU1720051108.HKD","LU1127390331.HKD","LU2417539215.USD","LU2552382132.HKD","LU2750360997.AUD","XLV","LU0225283273.USD","MEDI","TMED","IE00BFTCPJ56.SGD","LU0943347566.SGD","SG9999015945.SGD","LU2087625088.SGD","BK4588","IE00BK4W5L77.USD","LU0114720955.EUR","LU1035775433.USD","LU2756315664.SGD","LU1267930730.SGD","LU2552382058.USD","LU1814569148.SGD","LU2023250504.SGD","IE00BJJMRX11.SGD","LU2471134952.CNY","LU0471298777.SGD","LU1868836591.USD","LU2236285917.USD","VHT","LU0094547139.USD","LU1691799644.USD","IE00B4R5TH58.HKD","LU0203201768.USD","LU0238689110.USD","BK4533","LU1917777945.USD","LU0256863811.USD","MHIP","LU2361044949.HKD","LU2237438978.USD","LU2462591350.SGD","SGXZ99366536.SGD","IE00B7KXQ091.USD","LU2089984988.USD","LU2264538146.SGD","LU2491050154.USD","LU1069344957.HKD","JDOC","LU2602419157.SGD","LU2108987350.USD","SG9999001176.USD","LU2112291526.USD","LU1988902786.USD","BK4007","LU2237443382.USD","LU2271345857.HKD","IE00BKPKM429.USD","SG9999015986.USD","IYH","FTXH","LU1629891620.HKD","LU2028103732.USD","LU0058720904.USD","LU2213496289.HKD","LU0158827948.USD","LU0640476718.USD","LU1868836914.USD","LU2237443895.HKD","LU2265009873.SGD","LU1093756168.USD","LU2756315318.SGD","LU0323591593.USD","LU2168564222.USD","IE00BN29S564.USD","WDNA","FHLC","IE0002141913.USD","LU0882574139.USD","SG9999018857.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU2237443465.HKD","LU0354030438.USD","LU0672654240.SGD","LU2168564495.EUR","LLYZ","LU1989771016.USD","IXJ","LU0689472784.USD","IE00BWXC8680.SGD","LU0106261372.USD","IE0004445239.USD","LU0823434740.USD","SGXZ51526630.SGD","LU0964807845.USD","LU2468319806.SGD","LU2896262040.SGD","PPH","LU2491050071.SGD","LU0109394709.USD","LU0882574055.USD","TRUH","LU2456880835.USD","LU2237443549.SGD","LU0133085943.USD","BK4585","IE00B1BXHZ80.USD","LU1057294990.SGD","IE00BJLML261.HKD","IE0005OL40V9.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU2168563687.JPY","LU2237443978.SGD","LU2023251221.USD","LU2461242641.AUD","LU0266013472.USD","GDOC","LU1064131342.USD","LU1868837136.USD","RXL","LU1979441026.SGD","LU0096364046.USD","LU0353189763.USD","LU0353189680.USD","SG9999001176.SGD","LU0345770993.USD","LU0320765992.SGD","LU0316494557.USD","LU0471298694.HKD","LU2361044865.SGD","BK4581","ELIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":4,"totalSize":313,"code":"91000000","status":"200"}]}}